LTAS
FLGT icon

Linden Thomas Advisory Services’s Fulgent Genetics FLGT Stock Holding History

Linden Thomas Advisory Services’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$241K Sell
11,753
-105
-0.9% -$1.78K 0.02% 514
2026
Q1 		$189K Buy
+11,858
New +$257K 0.02% 528

Other funds holding FLGT

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
CMF
Counterpoint Mutual Funds San Diego, California $1.01B AUM 37.65% 1-Year Est. Return
MAM
Marquette Asset Management Minneapolis, Minnesota $779M AUM 23.4% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
ATC
Adirondack Trust Company Saratoga Springs, New York $336M AUM 29.2% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Linden Thomas Advisory Services's FLGT Position: Q2 2026 in Review

Linden Thomas Advisory Services reduced its Fulgent Genetics (FLGT) stake by 0.89% in Q2 2026, selling an estimated $1.78K and leaving 11,753 shares worth $241K. The position accounts for 0.02% of the portfolio, ranked #514.

Linden Thomas Advisory Services first reported a position in FLGT in Q1 2026 and has held it in 2 quarters since. 22 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • Linden Thomas Advisory Services held 11,753 shares of Fulgent Genetics worth $241K as of Q2 2026.
  • Linden Thomas Advisory Services sold 105 Fulgent Genetics shares in Q2 2026, an estimated $1.78K.
  • Fulgent Genetics made up 0.02% of Linden Thomas Advisory Services's portfolio in Q2 2026, its #514 holding.
  • Linden Thomas Advisory Services first reported a position in Fulgent Genetics in Q1 2026 and has held it in 2 quarters since.
  • 22 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Linden Thomas Advisory Services's 13F filing for Q2 2026, filed 16 Jul 2026.